The novel tRF-23 promotes osteogenic differentiation of hBMSCs and protects against bone loss in ovariectomized mice
Stem Cell Reports · 2025
DOI: 10.1016/j.stemcr.2025.102673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2025. Verfasst von Haichun Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China; Jiangxi Provincial Key Laborator…. Hauptthemen laut MEDLINE: Osteogenesis, Cell Differentiation, Mesenchymal Stem Cells, Osteoporosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
The pathogenesis of osteoporosis is closely related to the impaired human bone marrow-derived stromal cells (hBMSCs) osteogenic differentiation. No studies to date, however, have established whether tRNA-derived fragments (tRFs) can influence osteogenic differentiation of hBMSCs or the onset of osteoporosis. Here, tRF-23 was found to control hBMSC osteogenesis through its ability to target suppressor of cytokine signaling 1 (SOCS1) via the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. tRF-23 was then further established as a potential target for efforts to protect against bone loss and marrow adipose tissue (MAT) accumulation in osteoporotic model mice, and its molecular mechanism was also verified in vivo. Together, these results suggest a model in which tRF-23 can protect against bone loss induced by ovariectomized (OVX) through the augmentation of hBMSC osteogenesis, providing a foundation for characterizing the pathogenesis of osteoporosis and seeking new therapeutic targets for this disruptive condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China; Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujian…
- Department of Hematology and Oncology, Affiliated Hospital of Jiujiang University, Jiujiang 332005, China.
- Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China.
- Department of Thyroid and Breast Surgery, Affiliated Hospital of Jiujiang University, Jiujiang 332005, China.
- Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China. Electronic address: 6140074@jju.edu.cn.
- Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China. Electronic address: xiongjj1975@163.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Liao, H., Li, W., Xu, L., Zhao, C., Li, X., Xiong, J., & Wang, T. (2025). The novel tRF-23 promotes osteogenic differentiation of hBMSCs and protects against bone loss in ovariectomized mice. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2025.102673
Vancouver
Liao H, Li W, Xu L, Zhao C, Li X, Xiong J, et al. The novel tRF-23 promotes osteogenic differentiation of hBMSCs and protects against bone loss in ovariectomized mice. Stem Cell Reports. 2025. doi:10.1016/j.stemcr.2025.102673
BibTeX
@article{Liao2025,
author = {Liao, Haichun and Li, Wen and Xu, Lin and Zhao, Chao and Li, Xingnuan and Xiong, Jianjun and Wang, Tao},
title = {The novel tRF-23 promotes osteogenic differentiation of hBMSCs and protects against bone loss in ovariectomized mice},
journal = {Stem Cell Reports},
year = {2025},
doi = {10.1016/j.stemcr.2025.102673}
}
EUVIMED